Mannin Research is a biotechnology company focused on the discovery, development, and commercialization of first-in-class therapeutics for vascular related diseases using the Tie2 mechanism of action. Mannin’s Tie2 platform technology addresses a number of vascular related diseases. Mannin is currently developing host-directed therapeutics to treat Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients.
View Top Employees from Mannin Research| Website | http://www.mannin.ca |
| Revenue | $1 million |
| Employees | 13 (13 on RocketReach) |
| Founded | 2016 |
| Address | 629 Eastern Avenue, Suite C300, Toronto, Ontario M4M 1E4, CA |
| Phone | (416) 775-9767 |
| Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Drug Discovery, Medical, Health Care, Therapeutics |
| Competitors | Algernon Pharmaceuticals Inc., Phoenix Molecular Designs, Resverlogix Corp., Vasomune Inc, XORTX Therapeutics Inc. |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular Mannin Research employee's phone or email?
Mannin Research Questions
The Mannin Research annual revenue was $1 million in 2024.
Christopher Smith is the Executive Chairman of Mannin Research.
13 people are employed at Mannin Research.
Mannin Research is based in Toronto, Ontario.
The NAICS codes for Mannin Research are [541, 54, 54171, 541714, 5417].
The SIC codes for Mannin Research are [873, 87].
Top Mannin Research Employees
-
2
-
2
-
33
-
2
-
3
-
1
-
2
-
1
Related Companies
